Efficacy of checkpoint inhibition in advanced acral melanoma.

被引:0
|
作者
de Meza, Melissa Melanie
van Not, Olivier Jules
Blokx, Willeke
Bonenkamp, Han J.
Blank, Christian U.
van den Eertwegh, Alfonsus Johannes Maria
Aarts, Maureen J. B.
Stevense, Marion
van den Berkmortel, Franchette
Boers-Sonderen, Marye
de Groot, Jan Willem
Haanen, John B. A. G.
Hospers, Geke
Kapiteijn, Ellen
Piersma, Djura
Van Rijn, Rozemarijn
Van der Veldt, Astrid Aplonia Maria
Vreugdenhil, Gerard
Suijkerbuijk, Karijn
Wouters, Michel W. J. M.
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Leiden, Netherlands
[3] UMC Utrecht, Utrecht, Netherlands
[4] Radboudumc, Nijmegen, Netherlands
[5] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands
[6] VU Univ, Med Ctr, Amsterdam, Netherlands
[7] Maastricht Univ, Med Ctr, Maastricht, Netherlands
[8] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[9] Zuyderland Hosp, Heerlen, Netherlands
[10] Oncol Ctr Isala, Zwolle, Netherlands
[11] Netherlands Canc Inst, Amsterdam, Netherlands
[12] Groningen Univ, Med Ctr, Groningen, Netherlands
[13] Leiden Univ, Dept Med Oncol, Med Ctr, Leiden, Netherlands
[14] MST, Enschede, Netherlands
[15] Med Ctr Leeuwarden, Leeuwarden, Netherlands
[16] Erasmus Univ Med Ctr, Dept Med Oncol, Rotterdam, Netherlands
[17] Erasmus Univ Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[18] UMCU, Utrecht, Netherlands
[19] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands
关键词
D O I
10.1200/JCO.2021.39.15_suppl.e21527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21527
引用
收藏
页数:3
相关论文
共 50 条
  • [1] A prediction model for response to immune checkpoint inhibition in advanced melanoma.
    van Duin, Isabella A. J.
    Verheijden, Rik Jasper
    van Diest, Paul J.
    van den Eertwegh, Alfonsus Johannes Maria
    de Groot, Jan Willem
    van Not, Olivier Jules
    Aarts, Maureen J. B.
    Van den Berkmortel, Franchette
    Blank, Christian U.
    Haanen, John B. A. G.
    Hospers, Geke
    Piersma, Djura
    van Rijn, Rozemarijn
    Van der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Stevense-den Boer, Marion
    Boers-Sonderen, Marye J.
    Kapiteijn, Ellen
    Suijkerbuijk, Karijn
    Elias, Sjoerd G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Efficacy of immunotherapy and sequencing of checkpoint inhibition for metastatic ocular melanoma.
    Abhyankar, Anuja
    Maharaj, Satish
    Miller, Donald M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] BRAF and NRAS mutation status and response to checkpoint inhibition in advanced melanoma.
    van Not, Olivier Jules
    van den Eertwegh, Alfonsus Johannes Maria
    Haanen, John B. A. G.
    Blank, Christian U.
    Aarts, Maureen J. B.
    van den Berkmortel, Franchette
    de Groot, Jan Willem
    Hospers, Geke
    Kapiteijn, Ellen
    Piersma, Djura
    Van Rijn, Rozemarijn
    Stevense, Marion
    Van Der Veldt, Astrid Aplonia Maria
    Vreugdenhil, Gerard
    Boers-Sonderen, Marye
    Bonenkamp, Han J.
    Jansen, Anne M. L.
    Blokx, Willeke
    Wouters, Michel W. J. M.
    Suijkerbuijk, Karijn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Bhave, P.
    Ahmed, T.
    Shoushtari, A. N.
    Zaremba, A.
    Versluis, J. M.
    Mangana, J.
    Weichenthal, M.
    Si, L.
    Lesimple, T.
    Robert, C.
    Trojaniello, C.
    Wicky, A.
    Heywood, R.
    Tran, L.
    Batty, K.
    Stansfeld, A.
    Lebbe, C.
    Schwarze, J. K.
    Mooradian, M.
    Carlino, M.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S876 - S877
  • [5] Efficacy of checkpoint inhibitors (CPIs) in acral melanoma (AM)
    Bhave, Prachi
    Ahmed, Tasnia
    Shoushtari, Alexander
    Zaremba, Anne
    Versluis, Judith
    Mangana, Joanna
    Weichenthal, Michael
    Si, Lu
    Lesimple, Thierry
    Robert, Caroline
    Trojaniello, Claudia
    Wicky, Alexandre
    Heywood, Richard
    Tran, Lena
    Batty, Kathleen
    Stansfeld, Anna
    Lebbe, Celeste
    Schwarze, Julia K.
    Mooradian, Meghan
    Carlino, Matteo S.
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 64 - 65
  • [6] Efficacy and tolerability of vemurafenib in BRAF-mutant acral and mucosal melanoma.
    Bai, Xue
    Si, Lu
    Chi, Zhihong
    Sheng, Xinan
    Cui, Chuanliang
    Kong, Yan
    Dai, Jie
    Mao, Li Li
    Wang, Xuan
    Li, Si Ming
    Tang, Bixia
    Lian, Bin
    Zhou, Li
    Yan, Xieqiao
    Guo, Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Immune Checkpoint Inhibitors in Advanced Acral Melanoma: A Systematic Review
    Zheng, Qingyue
    Li, Jiarui
    Zhang, Hanlin
    Wang, Yuanzhuo
    Zhang, Shu
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [8] Dual Checkpoint Inhibition for Advanced Melanoma
    不详
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (05) : 1242 - 1242
  • [9] Checkpoint inhibition for advanced mucosal melanoma
    Thierauf, Julia
    Veit, Johannes A.
    Hess, Jochen
    Treiber, Nicolai
    Lisson, Catharina
    Weissinger, Stephanie E.
    Bommer, Martin
    Hoffmann, Thomas K.
    [J]. EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (02) : 160 - 165
  • [10] Checkpoint inhibition for advanced mucosal melanoma
    Julia Thierauf
    Johannes A. Veit
    Jochen Hess
    Nicolai Treiber
    Catharina Lisson
    Stephanie E. Weissinger
    Martin Bommer
    Thomas K. Hoffmann
    [J]. European Journal of Dermatology, 2017, 27 : 160 - 165